Protocol summary

Study aim
Effectiveness of oral clonidine on pain intensity and morphine requirement in patients with orthopedic fractures
Design
This double-blind randomized clinical trial study with parallel groups will be conducted on 64 patients with orthopedic fractures referred to Shahid Bahonar Hospital in Kerman. Patients participating in the study will be divided into two groups using a table of random numbers.
Settings and conduct
Patients referred to Shahid Bahoner Kerman Orthopedic Fracture Hospital will be included in the study. Patients participating in the study will be divided into two groups using a table of random numbers. The person participating in the study, the researcher and the person collecting the data will be unaware of the type of drug used.
Participants/Inclusion and exclusion criteria
Inclusion criteria: All patients referred to Shahid Bahonar Hospital in Kerman with orthopedic fractures who have consented to participate in the study. Non-exclusion criteria: It includes patients who do not have hemodynamic stability and suffer from acute and chronic pain.
Intervention groups
Intervention group 1: will receive 0.2 mg of oral clonidine. Intervention group 2: will receive placebo as a control group.
Main outcome variables
Pain

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220822055774N1
Registration date: 2022-09-20, 1401/06/29
Registration timing: prospective

Last update: 2022-09-20, 1401/06/29
Update count: 0
Registration date
2022-09-20, 1401/06/29
Registrant information
Name
Masomeh Nazemirafi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 34 3211 2955
Email address
m_nazemi@kmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-11-01, 1401/08/10
Expected recruitment end date
2023-03-02, 1401/12/11
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Clinical trial of the effectiveness of oral clonidine on pain severity and morphine requirement in patients with orthopedic fractures with history of opioids drug abuse in emergency ward
Public title
Clinical trial of the effectiveness of oral clonidine on pain severity and morphine requirement in patients with orthopedic fractures
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Patients over 18 years old with bone fractures, and pain score >5 based on VASS History of opioid drug abuse Consent to participate in the study
Exclusion criteria:
Pregnancy and breastfeeding women History of underlying cardio-pulmonary, renal diseases high blood pressure Thrombocytopenia Asthma Use of narcotics other than morphine The patient's urgent need for blood transfusion or resuscitation
Age
From 18 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 64
Randomization (investigator's opinion)
Randomized
Randomization description
Blocked randomization method will be used to allocate samples to intervention and control groups. In this way, an equal number of participants will enter the intervention and control groups at consecutive but equal intervals. Patients in each group will be divided into 6 blocks of 12 people. In this method, one type of treatment is given to the first block and another type to the second and again the first type to the third block and so on. A nurse who was not involved in the study, entered the patients in one of the two groups based on defined blocks.
Blinding (investigator's opinion)
Double blinded
Blinding description
For blinding in the current study, a double-blind method is used so that 1- the person who checks the results and 2- the person who performs the injections does not know which patient received clonidine and which patient received placebo. to be The person responsible for blinding (emergency nurse) will assign a code (01 to 70) to each patient and record it in the questionnaire. In this way, the intervention group received 0.2 mg of oral clonidine (23) and the control group received the same form of placebo pill. The person responsible for blinding will receive
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Kerman University of Medical Sciences
Street address
Kerman University of Medical Sciences campus, Haft Bagh Alavi, Kerman
City
Kerman
Province
Kerman
Postal code
7616914115
Approval date
2022-09-10, 1401/06/19
Ethics committee reference number
IR.KMU.REC.1401.262

Health conditions studied

1

Description of health condition studied
Bone fracture
ICD-10 code
M96.6
ICD-10 code description
Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate

Primary outcomes

1

Description
Pain
Timepoint
Before the intervention and 30 minutes, 1 hour, 3 hours and 6 hours after the intervention
Method of measurement
Visual pain intensity measurement scale

Secondary outcomes

1

Description
Hemodynamic symptoms (systolic and diastolic blood pressure, heart rate, arterial blood oxygen saturation)
Timepoint
Before the intervention and 30 minutes, 1 hour, 3 hours and 6 hours after the intervention
Method of measurement
Monitoring device

Intervention groups

1

Description
Intervention group 1: will receive 0.2 mg of oral clonidine after entering the emergency room.
Category
Treatment - Drugs

2

Description
Control group: They will receive placebo pills from the person responsible for blinding after entering the emergency room.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Bahonar Hospital
Full name of responsible person
Masoume Nazimi Rafi
Street address
Shahid Bahonar Hospital, Qorani St, Kerman
City
Kerman
Province
Kerman
Postal code
7613747181
Phone
+98 913 493 6949
Email
m_nazemi@kmu.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Reza Malekpour Afshar
Street address
Kerman, at the end of 22 Bahman Blvd., Shahid Bahonar University, Afzalipur Faculty of Medicine
City
Kerman
Province
Kerman
Postal code
7616914115
Phone
+98 34 3132 0500
Email
m-nazemi@kmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kerman University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Zahra Rostamipour
Position
Medical student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Afzalipour Faculty of Medicine, Shahid Bahonar University, end of 22 Bahman Blvd,Kerman
City
Kerman
Province
Kerman
Postal code
7616914115
Phone
31320500
Email
zahra.rostami.poor.2365@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Masoume Nazimi Rafi
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Afzalipour Faculty of Medicine, Shahid Bahonar University, end of 22 Bahman Blvd., Kerman
City
Kerman
Province
Kerman
Postal code
7616914115
Phone
31320500
Email
m-nazemi@kmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Zahra Rostamipour
Position
medical student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Afzalipour Faculty of Medicine, Shahid Bahonar University, end of 22 Bahman Blvd., Kerman
City
Kerman
Province
Kerman
Postal code
7616914115
Phone
31320500
Email
Zahra.Rostami.poor.2365@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...